Data
Data Show Non-White Patients With Advanced GI Cancer Less Likely to Use Opioids at EOL
Racial and ethnic disparities in access to opioids near the end of life (EOL) were observed among patients with gastrointestinal cancers, according...
Diversity in clinical trials in Europe and the US: a review of a pharmaceutical company's data collection, reporting, and interpretation of race an...
Editorial
. 2023 Sep 27;S0923-7534(23)03945-5.
doi: 10.1016/j.annonc.2023.09.3107.
Online ahead of print.
...
New Coalition Addresses Health Equity Challenges through Inclusive Data Collection
To improve health outcomes, groups join forces to standardize race, ethnicity, language, sexual orientation, and gender identity data collection
W...
Toward Improving Race and Ethnicity Data in Health Care (RAISE)
In this episode, RDML Araojo speaks with Susan Winckler, Chief Executive Officer of the Reagan-Udall Foundation (RUF) for the FDA, and Carla Rodrig...
Collection of Race and Ethnicity Data in Clinical Trials
Docket Number:
FDA-2016-D-3561
Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research
Center for Devices and Radiological He...
Diverse, Inclusive Data Leads to Better Health Outcomes and Healthier Communities — The National Minority Quality Forum
Â
For Immediate Release:
March 28, 2023
Contact:
press@bcbsa.com
akyerematen@nmqf.org
Â
Â
Diverse, Inclusive Data Leads to Better Health Outcomes ...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
